During the past decade, Duisburg Heart Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duisburg Heart Center" #1 collaborator was "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BMBf (Federal Ministry of Education and Research)" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Duisburg Heart Center" are "Coronary Artery Disease" (3 trials), "Heart Diseases" (2 trials), "Pulmonary Arterial Hypertension" (2 trials), "Atrial Flutter" (1 trials) and "Coronary Artery Bypass Grafting" (1 trials). Many other conditions were trialed in "Duisburg Heart Center" in a lesser frequency.

Most popular intervention types in "Duisburg Heart Center" are "Drug" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Multiple arterial grafting" (2 trials), "Single arterial graft" (2 trials), "Gold tip catheter" (1 trials), "Placebo" (1 trials) and "Platinum-iridium tip catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duisburg Heart Center" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Duisburg Heart Center". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Duisburg Heart Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Duisburg Heart Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".